Acumen Pharmaceuticals EPS ABOS

Diluted earnings per share by quarter and over the last twelve months, from 2020.

Acumen Pharmaceuticals' earnings per share was −$1.63 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.45.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$0.45	n/a	−$1.63
Q1 FY26	Mar 31, 2026	−$0.33	n/a	−$1.86
Q4 FY25	Dec 31, 2025	−$0.41	n/a	−$2.01
Q3 FY25	Sep 30, 2025	−$0.44	n/a	−$2.22
Q2 FY25	Jun 30, 2025	−$0.68	n/a	−$2.28
Q1 FY25	Mar 31, 2025	−$0.48	n/a	−$1.94
Q4 FY24	Dec 31, 2024	−$0.62	n/a	−$1.71
Q3 FY24	Sep 30, 2024	−$0.50	n/a	−$1.37
Q2 FY24	Jun 30, 2024	−$0.34	n/a	−$1.11
Q1 FY24	Mar 31, 2024	−$0.25	n/a	−$1.05
Q4 FY23	Dec 31, 2023	−$0.28	n/a	−$1.08
Q3 FY23	Sep 30, 2023	−$0.24	n/a	−$1.11

Companies in Healthcare nearest Acumen Pharmaceuticals' size, closest first, today.

Company	EPS, 12 months	Growth
ABOSAcumen Pharmaceuticals	−$1.63
PDEXPro DEX	$4.11	+52% a year
PLXProtalix BioTherapeutics	$0.23	+283% a year
NATRNatures Sunshine Products	$1.01	+36% a year
KEQUKewaunee Scientific	$2.76	−33% a year
ICCCImmucell	$0.08	−58% a year
ELMDElectromed	$1.31	+56% a year
UTMDUtah Medical Products	$3.28	−12% a year
INFUInfuSystem	$0.41	+78% a year
LFVNLifevantage	$0.40	−46% a year
SPROSpero Therapeutics	$0.11
Peer median	$0.71